PureTech to Present at The SVB Leerink 10th Annual Global Healthcare Conference

PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that Bharatt Chowrira, Ph.D., J.D., President and Chief of Business and Strategy, George Farmer, Ph.D., Chief Financial Officer, and Michael Chen, Ph.D., Head of Innovation, will participate in a fireside chat at the SVB Leerink 10^th Annual Global Healthcare Conference on Friday, February 26^th at 10:00 AM EST. A webcast of the presentation will be available at

Puretech Health

NASDAQ:PRTC

PRTC Rankings

#3573 Ranked by Market Cap

N/A Ranked by Dividends

PRTC Latest News

Oct 22, 2025

PureTech Presents New Phase 2b Analyses Demonstrating Consistent Safety and Efficacy of Deupirfenidone in Older Patients with Idiopathic Pulmonary Fibrosis (IPF), a Historically Undertreated Group

Sep 29, 2025

PureTech Presents New Data from Phase 2b Open-Label Extension Study of Deupirfenidone (LYT-100), Further Supporting Strong and Durable Efficacy and Potential to Serve as New Standard of Care in IPF

Sep 11, 2025

PureTech Founded Entity Seaport Therapeutics Advances Second Therapeutic Candidate into Clinical Development with Dosing of First Participant in Phase 1 Study of GlyphAgo™ (SPT-320) in Healthy Volunteers

Aug 28, 2025

PureTech Health plc – Half-Year Report

Aug 21, 2025

PureTech Showcases Differentiated Development Strategy, Including New Patient Preference Insights, and Spotlights Phase 2b Data Positioning Deupirfenidone as a Potential New Standard of Care in IPF

PRTC Latest SEC Filings

Aug 28, 2025

[6-K] PureTech Health plc American Current Report (Foreign Issuer)

Aug 11, 2025

[SCHEDULE 13G] PureTech Health plc American SEC Filing

Jul 16, 2025

[6-K] PureTech Health plc American Current Report (Foreign Issuer)

Jul 8, 2025

[6-K] PureTech Health plc American Current Report (Foreign Issuer)

PRTC Stock Data

Market Cap 410.87M

Float 24.17M

Institutions Ownership 1.47%

Short Percent 0.03%

Industry Biotechnology

Sector Healthcare

Website Link

Country United States

City Boston